Gastric Cancer

Study: Music therapy as effective as cognitive behavioral therapy for anxiety in cancer survivors

A study published in the Journal of Clinical Oncology found that music therapy delivered by telehealth worked just as well as cognitive behavioral therapy (CBT) to reduce anxiety among cancer survivors. Both approaches led to meaningful and lasting improvements, not only in anxiety, but also in sleep, fatigue and overall quality of life. These findings give patients more flexible, evidence-based options for managing emotional health after cancer. (posted 6/12/2026)

Topic: Gastrointestinal cancer survivorship in younger adults includes challenges often overlooked

This review summarizes a presentation given at the 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium. The presenter discussed survivorship concerns that younger adults with gastrointestinal (GI) cancer say their doctors often overlook. (posted 4/17/2026)

Study: Early trial of new vaccine shows promise for people with Lynch syndrome

The Nous-209 vaccine for preventing cancer in people with Lynch syndrome was tested in an early-phase study. The safety and immune response results were encouraging. An immune response was seen in most participants, suggesting that the vaccine may help reduce the chance of developing cancer in people with Lynch syndrome. (posted 3/23/2026)

Guideline: FDA recommends testing to prevent serious side effects from 5-FU and capecitabine chemotherapy

A small number of people treated with the chemotherapy drugs 5-FU (5-fluorouracil) or capecitabine (Xeloda) can have serious or even life-threatening side effects because their body breaks down the drug more slowly than is typical. A genetic test called DPYD testing can help identify people at higher risk for serious side effects before treatment starts. (posted 2/11/26)

Topic: What Patients Need to Know About Liquid Biopsies in Cancer Care

Liquid biopsies are tests that look for signs of cancer in blood or other body fluids. These signs can include cancer cells that have broken away from a tumor, pieces of cancer cell DNA and proteins or other biomarkers found in cancer cells. Liquid biopsies can be used to screen for cancer before a cancer diagnosis or guide treatment after a diagnosis. (posted 2/6/26)

Study: Lifetime cancer risks in people with an inherited mutation in CDH1

This study looked at the lifetime risks of stomach and breast cancer in families with a known CDH1 mutation. Results from the study suggest that for some CDH1 mutation carriers lifetime stomach cancer risk is lower than previous research has shown. Additionally, study results show that the lifetime risk of breast cancer is similar to previous lifetime risk estimates in women with mutations in this gene. (Posted 12/10/24)

Este artículo está disponible en español.

Study: H. pylori bacteria infection and risk of stomach cancer in mutation carriers

The results of a study in Japan show that people with a bacterial infection called H. pylori and an inherited mutation in an ATM, BRCA1, BRCA2 or PALB2 gene have a high risk of stomach cancer. This review has been updated to include the most recent NCCN guidelines on testing for H. pylori (updated 7/24/2026) (Posted 1/19/24)

Este artículo está disponible en español.

Article: A food lover’s decision to remove her stomach highlights difficult decisions around cancer risk

National Public Radio reporter Sáša Woodruff shares her story of learning about her CDH1 mutation and making a decision about risk-reducing surgery. Mutations in the CDH1 gene significantly increase a person’s risk of stomach and breast cancers. Woodruff’s personal essay describes the psychological challenge of making decisions about risk-reducing surgeries and draws attention to a lesser-known mutation linked to hereditary cancer. (Posted 5/17/23)

Este artículo está disponible en español.

Study: Resistant starch may help prevent some cancers in people with Lynch syndrome

This study looked at whether a type of nutrient known as resistant starch could lower the risk of cancers in people with Lynch Syndrome. Researchers found that resistant starch can reduce the risk of non-colorectal cancers but not colorectal cancer. (Posted 10/17/22)

Este artículo está disponible en español.

Study: Daily high-dose aspirin taken for at least 2 years reduces the risk of colorectal cancer but not other cancers in people with Lynch syndrome

Research has shown that daily aspirin use can reduce the risk of colon and other cancers. The Cancer Prevention Program 2 (CaPP2) study looked at the effect of daily aspirin in patients with Lynch syndrome. After 10 years of follow-up, the results showed that taking daily aspirin for two years reduced the frequency of colon cancer in patients with Lynch syndrome, and importantly, did not result in an increase in side-effects or complications. No benefit was seen for other Lynch syndrome-related cancers, including endometrial cancer. (5/17/21)

Este artículo está disponible en español.